	Secukinumab compared to ixekizumab in biologic-naÃ¯ve Chinese individuals afflicted with moderate-to-severe plaque psoriasis: A retrospective single-center analysis. Medicine (Baltimore) Zhao D. PMID: 41496152 [PubMed - indexed for MEDLINE]
	Determining the best discriminatory physical functioning outcome measurement instrument for psoriatic arthritis trials: A meta-epidemiological study. Semin Arthritis Rheum Leung YY, Haugegaard T, Annfeldt TK, Holland R, Strand V, Mease P, Tugwell P, Wells GA, Shea BJ, Mathew AJ, Goel N, Lindsay C, Ogdie A, Orbai AM, Coates LC, Gladman DD, Tillett W, Chau J, Christensen R. PMID: 41494365 [PubMed - as supplied by publisher]
	Evaluation of the Therapeutic and Economic Impact of Adalimumab Versus Methotrexate in the Management of Psoriasis: A Prospective Comparative Study. Cureus Shingala K, Nariya D, Chavda N, Busa P, Vora D. PMID: 41492593 [PubMed]
	Blood levels of brain-derived neurotrophic factor (BDNF) in psoriasis: a systematic review and meta-analysis. Adv Rheumatol Sarasyabi MS, Seighali N, Abdolmaleki M, Shobeiri P, Movahed MR, Bozorgnia F, Maleki S. PMID: 41491530 [PubMed - in process]
	Predictive Modeling of the Risk of Hyperglycemia in Psoriasis Patients Using Machine Learning: A Multicenter Retrospective Study. Clin Cosmet Investig Dermatol Hu M, Chen D, Yu J. PMID: 41488549 [PubMed]
	Efficacy of Probiotic Supplementation in the Management of Psoriasis: A Systematic Review. Cureus Waqas M, Sarwar I. PMID: 41487796 [PubMed]
	Psoriasis is not associated with high sodium excretion in a large retrospective cohort TriNetX study. J Eur Acad Dermatol Venereol Reich D, Singal A, Lipner HI, Lipner SR. PMID: 41487020 [PubMed - as supplied by publisher]
	The Brazilian Portuguese version of the psoriasis epidemiology screening tool (PEST-bp) is reliable and accurate: a cross-sectional study from southern Brazil. An Bras Dermatol Thomé V, Scalcon MRR, Antonelli da Veiga DT, de Vargas LP, Chagas P, Fagundes CS, Tudella GCN, Marques MD, Beber AAC, Chemello RML, Chemello D. PMID: 41483504 [PubMed - as supplied by publisher]
	Efficacy and safety of vunakizumab between super responders and non-super responders of patients with moderate-to-severe plaque psoriasis: a post-hoc exploratory analysis of a phase III trial. Naunyn Schmiedebergs Arch Pharmacol Liu O, Kou C, Yu S, Hu H, Chen X, Jiang M, Ren S. PMID: 41483190 [PubMed - as supplied by publisher]
	Photoprotective and anti-inflammatory potential of Tagetes erecta L. from southern coastal region of Pakistan: A study on psoriasis-prone skin. Pak J Pharm Sci Kamal S, Qamar F, Owais A, Akhtar F, Rahat M. PMID: 41482776 [PubMed - indexed for MEDLINE]
	The molecular mechanism of the adverse effects of the biological and small molecular drugs in the therapy of inflammatory skin diseases - psoriasis and atopic dermatitis. Ann Med Lemiesz P, Nowowiejska-Purpurowicz J, Flisiak I. PMID: 41481132 [PubMed - indexed for MEDLINE]
	Comment on "Real-world efficacy and retention of guselkumab in psoriatic arthritis: a 12-month multicenter study. ARP Rheumatol Bakay U. PMID: 41480890 [PubMed - indexed for MEDLINE]
	Increased antioxidant levels favor psoriasis risk reduction in specific populations: a cross-sectional study based on NHANES. Br J Nutr Peng L, Wang J, Gao C, Yang Y, Duan X, Mou K, Li P. PMID: 41480785 [PubMed - as supplied by publisher]
	Skin tone bias in online psoriasis imagery: Insights from an international study. World J Clin Cases Sandhu A, Ailani S, Padte S, Mehta P, Deo N, Surani S, Kashyap R. PMID: 41480060 [PubMed]
	Immunological Antagonism Between Psoriasis and Atopic Dermatitis: Pathways, Clinical Implications, and Therapeutic Perspectives. Clin Cosmet Investig Dermatol Qin J, Meng Z, Min W, Wang X, Zou Y. PMID: 41479810 [PubMed]
	Early Response to Vunakizumab at Week 2 Predicts Favourable Long-Term Efficacy in Patients With Moderate-To-Severe Plaque Psoriasis: A Post Hoc Analysis of a Phase III, Randomised Controlled Trial. Immunology Sun X, Zhang Y, Lu X, Tang S, Chen F, Sun Z, Li X. PMID: 41479228 [PubMed - as supplied by publisher]
	Serum Testosterone and Estradiol in Men with Psoriasis and Their Association with Disease Severity among Adult Male Patients. Mymensingh Med J Mokaddes HE, Chowdhury NS, Kaisar MA, Annur BM, Akhter R, Mannan M. PMID: 41474914 [PubMed - indexed for MEDLINE]
	Exploration of Targets Potentially Linked to IL-17A Inhibitor Response in Psoriasis Using Machine Learning. Clin Cosmet Investig Dermatol Wei Y, Liu M, Mou KH, Wang LJ, Zheng Y. PMID: 41473417 [PubMed]
	IL-6 as an integrative biomarker of residual inflammation and visceral adiposity in psoriasis: a VAI threshold-dependent model. Front Immunol Merzel , Kraner , Jani. PMID: 41472738 [PubMed - indexed for MEDLINE]
	Psychiatric Comorbidities in Patients with Psoriasis: A 10-Year Retrospective Epidemiological Study from a Tertiary University Center in Northeastern Romania. Medicina (Kaunas) Tarcau BM, Vata D, Popescu IA, Temelie Olinici D, Patrascu AI, Postu A, Halip IA, Mocanu M, Gaina MA, Gheuca Solovastru L. PMID: 41470192 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 27258

Page 1 of 1363



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy